Latest news with #TerumoCorporation
Business Standard
10 hours ago
- Business
- Business Standard
Terumo India is Great Place to Work®- Certified for the Fourth Time
VMPL New Delhi [India], June 23: Terumo India, the Indian arm of global medical technology leader Terumo Corporation (TSE: 4543), has been recognized as a Great Place to Work® for the fourth time, strengthening its position as an employer of choice in the healthcare industry. The certification also reaffirms the company's ongoing commitment to cultivating a culture of trust, respect, and associate well-being, aligned with Terumo's EVP statement of "Advancing Healthcare with Heart." The Great Place to Work® Certification is a globally respected benchmark for workplace culture. Terumo India's recognition followed a rigorous evaluation process, including anonymous associate feedback, a culture audit of people practices, and in-depth interactions across all levels of the organization. Achieving this certification for the fourth time in a row demonstrates Terumo India's success in consistently creating a work environment where associates thrive and feel valued. "Securing the Great Place to Work® Certification for the fourth time is a proud moment for all of us at Terumo India. This achievement reflects the collaborative spirit we've nurtured--where every associate feels respected, valued, and empowered. Our people are at the core of our success, and this recognition validates the inclusive and growth-driven culture we've worked tirelessly to build. I'm incredibly proud of our team's dedication and remain committed to ensuring an environment where everyone can thrive and contribute meaningfully to our mission of Contributing to Society through Healthcare," said Shishir Agarwal, President and Managing Director, Terumo India. Commenting on the achievement Ritu Anand, Vice President - Human Resources and Corporate Communications, Terumo India said "This recognition reflects our continued focus on listening, supporting, and growing together as an organization. At Terumo India, we are deeply guided by our 'Powered by People' philosophy, and we understand that the most successful workplaces are those that offer opportunities for both personal and professional growth. Being certified for the fourth time motivates us to continue fostering a culture where everyone feels a strong sense of belonging and purpose" This vision of creating a happier, healthier, and inspired workforce continues to guide Terumo India's HR strategy and people-centric approach. As part of its commitment to associate well-being, the company offers a wide range of initiatives from flexible work arrangements and wellness programs to continuous learning and leadership development opportunities. Programs like #TerumoCares provide holistic support to associates, helping them balance both personal and professional responsibilities. About Terumo India Private Limited Terumo India is a rapidly growing medical devices company dedicated to advancing access to high-quality cardiac, vascular, and other medical devices for patients and healthcare practitioners in India. As part of Terumo Corporation, a global leader in medical technology headquartered in Tokyo, Japan, Terumo India upholds a mission rooted in 100 years of history: 'Contributing to Society through Healthcare.' Founded in 2013 and headquartered in Gurgaon, NCR Delhi, Terumo India has touched over 100,000 lives. The company is three times Great Place to Work® certified and was also recognized as one of India's Top 15 Workplaces™ in Pharmaceuticals, Healthcare, and Biotech in 2022. Terumo India also runs several acclaimed training and development programs, collaborating closely with customers and academic partners to address the skilling needs of India's healthcare system. For more information, visit About Terumo Terumo (TSE: 4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large. For more information, visit (ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same)
Yahoo
27-05-2025
- Business
- Yahoo
Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System
– Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures – SOMERSET, N.J., May 27, 2025 /PRNewswire/ -- Terumo Interventional Systems (TIS), a division of Terumo Corporation, is pleased to announce the early commercial availability of its FDA-approved ROADSAVER™ Carotid Stent System. Indicated for use with the Nanoparasol® Embolic Protection System, ROADSAVER Stent System addresses carotid artery stenosis in patients with increased risk of adverse events following carotid endarterectomy. ROADSAVER Stent System is the only carotid artery stenting (CAS) device with an innovative, dual-layer micromesh. It is designed as a closed-cell stent with the flexibility of an open-cell stent, providing increased flexibility and wall apposition in complex anatomies. It is also the first dual-layer micromesh carotid stent approved in the United States, and the only carotid stent system designed to contain plaque to the vessel wall and prevent plaque protrusion, protecting against distal embolization. Available in sizes from 5 to 10 mm in width and 22 to 47 mm in length, ROADSAVER Stent System has a rapid-exchange shaft length of 143 cm. It is also fully re-sheathable and repositionable – even after 50% of the stent's length is deployed. Another important feature is the product's low-profile 5Fr design, which enhances its crossability. "ROADSAVER Stent System is yet another example of our unrelenting pursuit of achieving better outcomes for patients," said Chris Pearson, Executive Vice President – US Commercial Operations, Terumo Interventional Systems. "Its rapid delivery and accurate placement drive procedure predictability and efficiency, differentiating it from other carotid artery stents on the market and providing a level of confidence unmatched in the industry." "An inner micromesh layer with a pore size four-times smaller than any carotid stent which provides sustained embolic protection makes the ROADSAVER Stent System a leading technology in the evolution of CAS," said Michael J. Martinelli, MD, FACC, FSCAI and Chief Medical Officer, Terumo Medical Corporation. "This is supported by the results of clinical trials, which demonstrated that using ROADSAVER for symptomatic patients with high-risk lesions is safe and effective, with a low complication rate." Limited market release of the ROADSAVER Carotid Stent System is planned for summer 2025, with full market release anticipated in fall 2025. About Terumo Interventional Systems Terumo Interventional Systems (TIS), a division of Terumo Corporation, is a market leader in minimally invasive entry site management, lesion access, and therapeutic intervention. TIS offers a complete, solution-based product portfolio used in advanced coronary, peripheral and endovascular treatments with strategic initiatives in Transradial Access, Complex Coronary Intervention, Peripheral Artery Disease and Embolotherapy. TIS combines innovative research and development with a deep market understanding to create a pipeline of industry-leading devices that deliver clinical value, economic benefit, and enhanced patient outcomes. About Terumo Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for over 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large. More information can be found at ROADSAVERINDICATIONS FOR USE The Roadsaver Carotid Stent System, when used in conjunction with the Nanoparasol Embolic Protection System (EPS), is indicated for the treatment of carotid artery stenosis in patients with elevated risk for adverse events following carotid endarterectomy and meet the criteria outlined below: Patients who have either de novo atherosclerotic or post endarterectomy restenotic lesion(s) in the internal carotid arteries or at the carotid bifurcation with ≥50% stenosis if symptomatic or ≥80% stenosis if asymptomatic (both defined by angiography),AND Patients having a vessel with reference diameters between 3.5 mm and 9.0 mm at the target lesion. CONTRAINDICATIONS The Roadsaver Carotid Stent System is contraindicated for use in: Patients in whom anticoagulant, antiplatelet therapy or thrombolytic drugs are contraindicated Patients with known hypersensitivity to nickel-titanium Patients with severe vascular tortuosity or anatomy that would preclude the safe introduction of a guide catheter, sheath, embolic protection system, or stent system Patients with uncorrected bleeding disorders Lesions in the ostium of the common carotid artery Carotid vessel with <25mm gap between the target location of the distal end of the stent and the proximal end of the distal protection device. NANOPARASOL EPSINDICATIONS FOR USE The Nanoparasol EPS is indicated for use as a guidewire to contain and remove embolic material (thrombus/debris) while performing angioplasty and stenting procedures in carotid arteries. The diameter of the artery at the site of the filter placement should be between 3.0 and 6.5 mm. CONTRAINDICATIONS The Nanoparasol EPS is contraindicated for use in: Patients in whom anticoagulant, antiplatelet therapy or thrombolytic drugs is contraindicated Patients with known hypersensitivity to nickel-titanium Patients with severe vascular tortuosity or anatomy that would preclude the landing zone requirement or the safe introduction of a guide wire, guide catheter, introducer sheath, an embolic protection device, delivery catheter, or retrieval catheter Patients with uncorrected bleeding disorders Lesions in the ostium of the common carotid artery RX ONLY. Refer to the product labels and package insert for complete contraindications, warnings, precautions, potential complications, and instructions for use. Manufacturer: Terumo Neuro, 35 Enterprise, Aliso Viejo, CA 92656, USA Distributed by Terumo Medical Corporation, 265 Davidson Ave, Somerset, NJ 08873, USA ©2025 Terumo Medical Corporation. All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties. View original content to download multimedia: SOURCE Terumo Interventional Systems Sign in to access your portfolio
Yahoo
20-03-2025
- Business
- Yahoo
[Latest] Global Elastomeric Infusions Pumps Market Size/Share Worth USD 1,369.81 Million by 2034 at a 7.28% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Elastomeric Infusions Pumps Market size & share revenue was valued at approximately USD 678.38 Million in 2024 and is expected to reach USD 727.77 Million in 2025 and is expected to reach around USD 1,369.81 Million by 2034, at a CAGR of 7.28% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Vygon Group, Terumo Corporation, Smiths Group plc, NIPRO, Leventon S.A.U., Fresenius Kabi AG, Baxter, B. Braun SE, AVNS, Ambu A/S, Daiken Medical Co. Ltd, Woo Young Medical Co, Epic Medical Pte Ltd, Moog Inc., Halyard Health, and others. Austin, TX, USA, March 21, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled 'Elastomeric Infusions Pumps Market Size, Trends and Insights By Product (Variable Rate, Continuous Rate), By Application (Antibiotic/Antiviral Therapy, Chemotherapy, Pain Management, Others), By End-Use (Ambulatory Surgical Centers, Hospitals, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034' in its research database. 'According to the latest research study, the demand of global Elastomeric Infusions Pumps Market size & share was valued at approximately USD 678.38 Million in 2024 and is expected to reach USD 727.77 Million in 2025 and is expected to reach a value of around USD 1,369.81 Million by 2034, at a compound annual growth rate (CAGR) of about 7.28% during the forecast period 2025 to 2034.' Click Here to Access a Free Sample Report of the Global Elastomeric Infusions Pumps Market @ Elastomeric Infusions Pumps Market Growth Factors Integration of Digital Technologies: One of the most important trends right now in the elastomer infusion pumps market is digital technology integration. Manufacturers are embedding smart sensors, wireless connectivity, and data analytics into their devices, transforming traditional pumps into intelligent systems. These upgrades let us monitor things in real time and control everything remotely. They also let us make precise tweaks to dosing which all together means higher safety and better efficacy of treatment. Digital integration also means collecting lots of data and figuring out what that means. That's important too since being ready to make clinical decisions quicker and with even better products helps us all improve. As healthcare systems increasingly adopt digital solutions, the convergence of infusion pump technology with modern IT infrastructure is reshaping market dynamics and driving substantial growth opportunities for innovative manufacturers. Expansion of Home Healthcare: Expansion of home healthcare is a big trend that's really shifting the market for those squeeze pumps used to deliver medicine. More and more patients are preferring not to treat inside hospitals, which has really sparked demand for lightweight and good to use devices that deliver infusions whenever and wherever the patient might be. Elastomeric pumps provide a reliable solution for administering medications in home care environments, reducing hospital stays and costs. This trend is backed even more by really cool new tech like telemedicine and remote health monitoring that enhances patient care and leads to way better results. Manufacturers are responding by designing lightweight, efficient, and safe devices tailored for at-home use. Consequently, the growing emphasis on decentralized care models is significantly accelerating market growth. This shift enhances industry innovation globally. Request a Customized Copy of the Elastomeric Infusions Pumps Market Report @ Growing Demand in Emerging Markets: Growing demand in emerging markets is a big trend for the infusion pump biz powered by elastic materials. As these countries grow and people get wealthier and healthier, they want to buy more medical pumps that are soft and stretchy. That's why people are seeing more interesting things in pumps made of rubber and related materials. Rapid economic development, expanding healthcare infrastructure, and increasing patient awareness in regions such as Asia-Pacific, Latin America, and Africa are fueling market growth. These regions are witnessing significant investments in modern medical technologies, leading to enhanced access to advanced drug delivery systems. As newer economies are focused on finding costs effective and reliable healthcare solutions, they start opting more and more for those great elastomer infusion pumps. The manufacturers are tailoring the way things work to really fit in with what people in different places desperately need. This is really making consumers want to buy their stuff more and they're also finding new markets where they haven't made sales before really, customer by customer they are opening new business streams. Strategic Partnerships and Collaborations: Strategic partnerships and collaborations are emerging as vital trends in the elastomeric infusion pumps market. Leading manufacturers are forming alliances with healthcare providers, research institutions, and regional distributors to expand their market reach and drive innovation. Such collaborations facilitate technology sharing, cost reduction, and enhanced regulatory compliance, accelerating product development and market entry. Working together and sharing ideas and equipment helps us design better litmus devices that perfectly meet the diverse needs of all the different patients. This cooperative approach not only boosts competitive advantage but also fosters industry-wide advancements, resulting in improved patient care and market growth in a healthcare landscape. Focus on R&D and Innovation: Focused investment in research and development (R&D) and innovation is a key trend shaping the elastomeric infusion pumps market. Manufacturers are dedicating resources to developing innovative devices that incorporate advanced materials, ergonomic designs, and integrated digital features. This innovation drive really improves accuracy and safety of pumps and makes them easier to use. Ultimately this leads to great health outcomes for sick people. Enhanced R&D efforts are also enabling faster regulatory approvals and market entry for new products. Companies are teaming up with schools and top doctors and scientists to see where infusion technology can go next. They ensure that their current technology can adapt to sudden changes in the healthcare space, enabling them to stay at the forefront of this constantly evolving world. Rising Prevalence of Chronic Diseases: Rising prevalence of chronic diseases is a key driver influencing the elastomeric infusion pumps market. As more and more people are being diagnosed with serious health issues like cancer, diabetes and heart problems, there's growing demand for steady and controlled systems to dispense medications continuously. Elastomeric infusion pumps offer a reliable and cost-effective solution for managing long-term therapies in both inpatient and outpatient settings. This trend stands because the world is seeing more and older people with people changing lifestyles leading to higher incidence of sickness all around the globe. So healthcare pros are picking up these devices to constantly improve patient adherence to treatment, reduce hospital stays and make patient results a whole lot better. They're driving market growth and really cool tech upgrades too at the same time. Report Scope Feature of the Report Details Market Size in 2025 USD 727.77 Million Projected Market Size in 2034 USD 1,369.81 Million Market Size in 2024 USD 678.38 Million CAGR Growth Rate 7.28% CAGR Base Year 2024 Forecast Period 2025-2034 Key Segment By Product, Application, End-Use and Region Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America Buying Options Request tailored purchasing options to fulfil your requirements for research. (A free sample of the Elastomeric Infusions Pumps report is available upon request; please contact us for more information.) Our Free Sample Report Consists of the following: Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. The COVID-19 Pandemic Outbreak Impact Analysis is included in the package. About 220+ Pages Research Report (Including Recent Research) Provide detailed chapter-by-chapter guidance on the Request. Updated Regional Analysis with a Graphical Representation of Size, Share, and Trends for the Year 2025 Includes Tables and figures have been updated. The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis Custom Market Insights (CMI) research methodology (Please note that the sample of the Elastomeric Infusions Pumps report has been modified to include the COVID-19 impact study prior to delivery.) Request a Customized Copy of the Elastomeric Infusions Pumps Market Report @ Elastomeric Infusions Pumps Market SWOT Analysis Strengths: The lightweight and compact design allow patients to maintain mobility and continue with their daily activities while receiving necessary therapy. This feature is especially valuable as healthcare systems increasingly focus on providing advanced treatments outside of traditional hospital settings. The operational simplicity of elastomeric infusion pumps is another key strength. Unlike electronic pumps that often require complex programming, elastomeric pumps are generally straightforward to use, with pre-set flow rates that do not necessitate intricate adjustments by healthcare personnel during infusion. Weakness: Compared to modern electronic infusion pumps, the accuracy of elastomeric pumps can be lower. Elastomeric infusion pumps are inherently dependent on external environmental factors, which can influence their performance. Temperature changes, for instance, can significantly affect the viscosity of the medication within the pump, leading to alterations in the flow rate. Opportunities: The increasing preference for home-based healthcare solutions presents a significant growth opportunity for the elastomeric infusion pumps market. The rising global prevalence of chronic diseases, including cancer, diabetes, and cardiovascular disorders, is a major factor driving the growth of the elastomeric infusion pumps market. Manufacturers are focusing on enhancing the accuracy, safety features, and overall user-friendliness of these devices. Threats: The elastomeric infusion pumps market operates within a highly regulated landscape, with stringent requirements imposed by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). The elastomeric infusion pumps market faces significant competition from advanced electronic infusion pumps. Despite their advantages, elastomeric infusion pumps carry a potential risk of dosage errors due to factors such as incorrect configuration, variability in flow rates caused by external conditions, or device-related issues. Request a Customized Copy of the Elastomeric Infusions Pumps Market Report @ Key questions answered in this report: What is the size of the Elastomeric Infusions Pumps market and what is its expected growth rate? What are the primary driving factors that push the Elastomeric Infusions Pumps market forward? What are the Elastomeric Infusions Pumps Industry's top companies? What are the different categories that the Elastomeric Infusions Pumps Market caters to? What will be the fastest-growing segment or region? In the value chain, what role do essential players play? What is the procedure for getting a free copy of the Elastomeric Infusions Pumps market sample report and company profiles? Key Offerings: Market Share, Size & Forecast by Revenue | 2025−2034 Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Leading Trends Market Segmentation – A detailed analysis by Types of Services, by End-User Services, and by regions Competitive Landscape – Top Key Vendors and Other Prominent Vendors Buy this Premium Elastomeric Infusions Pumps Research Report | Fast Delivery Available - [220+ Pages] @ Elastomeric Infusions Pumps Market Regional Analysis The Elastomeric Infusions Pumps Market is segmented into various regions, including North America, Europe, Asia-Pacific, and LAMEA. Here is a brief overview of each region: North America: In North America, the market is primarily defined by the robust healthcare systems, eventual demand, and a strong focus on home healthcare. Hospitals and ambulatory surgical and other outpatient centers are increasingly adopting elastomeric infusion pumps for advanced drug delivery hence improving patient outcomes. In North America, U.S. dominates the market due to the strongest healthcare systems and the epitome of investment in health technology. USA hospitals and outpatient centers are fast using these pumps for uninterrupted and accurate drug delivery for pain management, chemotherapy, and infection control. Europe: In Europe, the market corresponds to very explicit and stringent regulation(s) embedded in high-quality healthcare infrastructures that have already been completely core-aligned. This demand is perennial as the aging population in this territory, alongside the onslaught of chronic diseases, all make us want more home healthcare for healthcare givers here critically. Going by the high demand in precision and reliability in drug delivery in European hospitals and outpatient clinics, that has triggered the further steps of investment in alternative infusion technology everywhere. Such considerable market penetration is tailored to cooperate with eligible players, further support government measures and considerations. Asia-Pacific: Asia-Pacific is a vibrantly growing region with an expanding healthcare setup and parallelly a demand for homecare solutions. Chronic diseases are rampant, and the aging population makes them look for round-the-clock reliable drug delivery systems. Manufacturers are now investing in technologies to have a product that can cater to a spectrum of clinical needs peculiar to emerging markets. State-backed activities and improving regulatory modules show the way for the segment. LAMEA: Futuristic is the ideal word to describe LAMEA's elastomeric infusion pumps market-triggered by the revamping of health infrastructure and large-scale investments in health technology. This segment is still going through colossally high growth simply because people in this particular place are being made aware of advanced drug delivery systems, and the rise in chronic diseases is also resulting in a massive pull from hospitals, outpatient clinics, and homecare settings. Government functions are also working in tandem with global manufacturers in enhancing market penetration. Upcoming challenges-with regulatory variation and a severe lack of rigid supply chain-endow to a mind-blowing growth through new product launches and strategic alliances. Request a Customized Copy of the Elastomeric Infusions Pumps Market Report @ (We customized your report to meet your specific research requirements. Inquire with our sales team about customizing your report.) Still, Looking for More Information? Do OR Want Data for Inclusion in magazines, case studies, research papers, or Media? Email Directly Here with Detail Information: support@ Browse the full 'Elastomeric Infusions Pumps Market Size, Trends and Insights By Product (Variable Rate, Continuous Rate), By Application (Antibiotic/Antiviral Therapy, Chemotherapy, Pain Management, Others), By End-Use (Ambulatory Surgical Centers, Hospitals, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034' Report at List of the prominent players in the Elastomeric Infusions Pumps Market: Vygon Group Terumo Corporation Smiths Group plc NIPRO Leventon S.A.U. Fresenius Kabi AG Baxter Braun SE AVNS Ambu A/S Daiken Medical Co. Ltd Woo Young Medical Co Epic Medical Pte Ltd Moog Inc. Halyard Health Others Click Here to Access a Free Sample Report of the Global Elastomeric Infusions Pumps Market @ Spectacular Deals Comprehensive coverage Maximum number of market tables and figures The subscription-based option is offered. Best price guarantee Free 35% or 60 hours of customization. Free post-sale service assistance. 25% discount on your next purchase. Service guarantees are available. Personalized market brief by author. Browse More Related Reports: Duchenne Muscular Dystrophy Drugs Market: Duchenne Muscular Dystrophy Drugs Market Size, Trends and Insights By Drug Type (Exon skipping drugs, Corticosteroids, Gene therapy, Other drug types), By Route of Administration (Oral, Injectable), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Psychiatric Digital Biomarkers Market: Psychiatric Digital Biomarkers Market Size, Trends and Insights By Type (Wearable, Mobile based Applications, Sensors, Other Type), By Clinical Practice (Diagnostic Psychiatric Digital Biomarkers, Monitoring Psychiatric Digital Biomarkers, Predictive and Prognostic Psychiatric Digital Biomarkers, Other Clinical Practice), By End Use (Healthcare Companies, Healthcare Providers, Payers, Other End Use), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034 Electrophysiology Devices Market: Electrophysiology Devices Market Size, Trends and Insights By Type (Ablation Catheters, Diagnostic Catheters, Mapping System, Accessories, Others), By Application (Atrial Fibrillation, Supraventricular Tachycardia (SVT), Ventricular Tachycardia, Others), By End User (Hospitals & ASCs, Specialty Clinics & Diagnostic Centers), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Egg Donation Market: Egg Donation Market Size, Trends and Insights By Type of Egg Donation (Fresh Donor Eggs, Frozen Donor Eggs), By Age Group of Donors (21–25 Years, 26–30 Years, 31–35 Years), By End User (Individuals (Intended Parents), LGBTQ+ Community, Medical Research Institutes), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Prosthetic Arm Market: Prosthetic Arm Market Size, Trends and Insights By Type (Activity-Specific Prosthesis, Hybrid Prosthesis, Electrically-Powered Prosthesis, Body-Powered Prosthesis, Passive Prosthesis), By Product Type (Transhumeral Prosthetic, Trasradial Prosthetic), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Prosthetic Disc Nucleus Market: Prosthetic Disc Nucleus Market Size, Trends and Insights By Type (Open Spine Surgery, Minimally Invasive Spine Surgery), By End User (Ambulatory Surgery Centers, Hospitals, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 HbA1c Testing Devices Market: HbA1c Testing Devices Market Size, Trends and Insights By Type of Device (Laboratory-based Testing Devices, Point-of-care (POC) Testing Devices), By End User (Hospitals & Clinics, Diagnostic Laboratories, Homecare Settings), By Technology (Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High-Performance Liquid Chromatography, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 Oncology Molecular Diagnostic Market: Oncology Molecular Diagnostic Market Size, Trends and Insights By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer, Other Cancer), By Product (Instruments, Reagents, Others), By Technology (PCR, In Situ Hybridization, INAAT, Chips and Microarrays, Mass Spectrometry, Sequencing, TMA, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034 The Elastomeric Infusions Pumps Market is segmented as follows: By Product Variable Rate Continuous Rate By Application Antibiotic/Antiviral Therapy Chemotherapy Pain Management Others By End-Use Ambulatory Surgical Centers Hospitals Others Click Here to Get a Free Sample Report of the Global Elastomeric Infusions Pumps Market @ Regional Coverage: North America U.S. Canada Mexico Rest of North America Europe Germany France U.K. Russia Italy Spain Netherlands Rest of Europe Asia Pacific China Japan India New Zealand Australia South Korea Taiwan Rest of Asia Pacific The Middle East & Africa Saudi Arabia UAE Egypt Kuwait South Africa Rest of the Middle East & Africa Latin America Brazil Argentina Rest of Latin America This Elastomeric Infusions Pumps Market Research/Analysis Report Contains Answers to the following Questions. Which Trends Are Causing These Developments? Who Are the Global Key Players in This Elastomeric Infusions Pumps Market? What are Their Company Profile, Product Information, and Contact Information? What Was the Global Market Status of the Elastomeric Infusions Pumps Market? What Was the Capacity, Production Value, Cost and PROFIT of the Elastomeric Infusions Pumps Market? What Is the Current Market Status of the Elastomeric Infusions Pumps Industry? What's Market Competition in This Industry, Both Company and Country Wise? What's Market Analysis of Elastomeric Infusions Pumps Market by Considering Applications and Types? What Are Projections of the Global Elastomeric Infusions Pumps Industry Considering Capacity, Production and Production Value? What Will Be the Estimation of Cost and Profit? What Will Be Market Share, Supply and Consumption? What about imports and exports? What Is Elastomeric Infusions Pumps Market Chain Analysis by Upstream Raw Materials and Downstream Industry? What Is the Economic Impact On Elastomeric Infusions Pumps Industry? What are Global Macroeconomic Environment Analysis Results? What Are Global Macroeconomic Environment Development Trends? What Are Market Dynamics of Elastomeric Infusions Pumps Market? What Are Challenges and Opportunities? What Should Be Entry Strategies, Countermeasures to Economic Impact, and Marketing Channels for Elastomeric Infusions Pumps Industry? Click Here to Access a Free Sample Report of the Global Elastomeric Infusions Pumps Market @ Reasons to Purchase Elastomeric Infusions Pumps Market Report Elastomeric Infusions Pumps Market Report provides qualitative and quantitative analysis of the market based on segmentation involving economic and non-economic factors. Elastomeric Infusions Pumps Market report outlines market value (USD) data for each segment and sub-segment. This report indicates the region and segment expected to witness the fastest growth and dominate the market. Elastomeric Infusions Pumps Market Analysis by geography highlights the consumption of the product/service in the region and indicates the factors affecting the market within each region. The competitive landscape incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled. Extensive company profiles comprising company overview, company insights, product benchmarking, and SWOT analysis for the major market players. The Industry's current and future market outlook concerning recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging and developed regions. Elastomeric Infusions Pumps Market Includes in-depth market analysis from various perspectives through Porter's five forces analysis and provides insight into the market through Value Chain. Reasons for the Research Report The study provides a thorough overview of the global Elastomeric Infusions Pumps market. Compare your performance to that of the market as a whole. Aim to maintain competitiveness while innovations from established key players fuel market growth. Buy this Premium Elastomeric Infusions Pumps Research Report | Fast Delivery Available - [220+ Pages] @ What does the report include? Drivers, restrictions, and opportunities are among the qualitative elements covered in the worldwide Elastomeric Infusions Pumps market analysis. The competitive environment of current and potential participants in the Elastomeric Infusions Pumps market is covered in the report, as well as those companies' strategic product development ambitions. According to the component, application, and industry vertical, this study analyzes the market qualitatively and quantitatively. Additionally, the report offers comparable data for the important regions. For each segment mentioned above, actual market sizes and forecasts have been given. Who should buy this report? Participants and stakeholders worldwide Elastomeric Infusions Pumps market should find this report useful. The research will be useful to all market participants in the Elastomeric Infusions Pumps industry. Managers in the Elastomeric Infusions Pumps sector are interested in publishing up-to-date and projected data about the worldwide Elastomeric Infusions Pumps market. Governmental agencies, regulatory bodies, decision-makers, and organizations want to invest in Elastomeric Infusions Pumps products' market trends. Market insights are sought for by analysts, researchers, educators, strategy managers, and government organizations to develop plans. Request a Customized Copy of the Elastomeric Infusions Pumps Market Report @ About Custom Market Insights: Custom Market Insights is a market research and advisory company delivering business insights and market research reports to large, small, and medium-scale enterprises. We assist clients with strategies and business policies and regularly work towards achieving sustainable growth in their respective domains. CMI provides a one-stop solution for data collection to investment advice. The expert analysis of our company digs out essential factors that help to understand the significance and impact of market dynamics. The professional experts apply clients inside on the aspects such as strategies for future estimation fall, forecasting or opportunity to grow, and consumer survey. Follow Us: LinkedIn | Twitter | Facebook | YouTube Contact Us: Joel John CMI Consulting LLC 1333, 701 Tillery Street Unit 12, Austin, TX, Travis, US, 78702 USA: +1 801-639-9061 India: +91 20 46022736 Email: support@ Web: Blog: Blog: Blog: Blog: Buy this Premium Elastomeric Infusions Pumps Research Report | Fast Delivery Available - [220+ Pages] @
Associated Press
19-03-2025
- Health
- Associated Press
Terumo Neuro Celebrates 15 Years of the WEB™ Device: A Game-Changing Innovation in Aneurysm Treatment
More than 25,000 Devices Implanted Worldwide from 2010-20251 ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of the groundbreaking WEB™ Aneurysm Embolization System. Since its introduction, the WEB device has transformed the treatment of wide-neck bifurcation aneurysms, offering physicians and patients a clinically proven, single-device solution – One and Done – with proven simplicity, proven safety and durability, proven for ruptured aneurysms* and proven innovation2-9. The WEB device was commercially launched in October 2010 after receiving its CE (Conformité Européenne) Mark in Europe. The first implant was performed by Prof. Joachim Klisch in Germany, paving the way for a new era in aneurysm treatment. The WEB device has proven clinical data, supported by seven global Good Clinical Practice (GCP) studies2-8 and over 200 peer-reviewed publications. Over the past 15 years, this revolutionary technology has changed the paradigm for aneurysm treatment, providing a safe, effective alternative to traditional methods. Carsten Schroeder, President and CEO of Terumo Neuro, commented on this significant milestone: 'The WEB device has set a new standard in aneurysm treatment and has been instrumental in our mission to drive game-changing impact in neurovascular care. With 15 years of proven clinical success, WEB continues to advance patient outcomes, reducing the need for multiple devices and lengthy procedures. As we celebrate this achievement, we remain committed to innovating alongside leading physicians worldwide to shape the future of neurovascular care.' Transforming Aneurysm Treatment with the WEB Device The WEB device is the world's first intrasaccular flow disruptor, designed to treat brain aneurysms from inside the aneurysm sac. Unlike traditional treatments for wide-neck bifurcation aneurysms that require stents and coils, this device minimizes the need for dual antiplatelet therapy, simplifying procedures and enhancing patient safety, with a single device. Key milestones and clinical highlights of Terumo Neuro's WEB embolization system include: Unparalleled Clinical Data: The WEB device has been studied in over 600 patients across seven GCP trials, accumulating more than 1,464 patient-years with zero recorded rebleeds in a WEB device-treated aneurysm.2-8 Proven Long-Term Safety & Durability: The five-year follow-up data from the WEB-IT, WEBCAST and WEBCAST 2 trials reaffirmed the WEB system's sustained efficacy and safety, including 0% device-related morbidity and mortality.7,8 Expanding Treatment Options: The introduction of the WEB 17 system, a lower profile system to treat smaller aneurysms, has further refined aneurysm treatment providing physicians with greater flexibility and precision for a wider range of cases. The WEB device's continued evolution underscores Terumo Neuro's dedication to advancing neurovascular technology. With more than 25,000 patients treated with the WEB device worldwide, this intrasaccular device remains the trusted choice for physicians seeking a reliable, single-device solution for wide-neck bifurcation aneurysms. About Terumo Neuro (Formerly MicroVention, Inc.) We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neuroendovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica. For more information on Terumo Neuro, please visit About Terumo Corporation Terumo (TSE:4543) is a global leader in medical technology and has been committed to 'Contributing to Society through Healthcare' for one hundred years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large. For full indications for use, visit: WEB™ Embolization System | Terumo Neuro *Information provided may not represent the approved indication for use for each country/market. Please refer to the Instruction for Use (IFU) in the specific market/country that you are looking into. References: Data on file, Terumo Neuro. Pierot L, Moret J, Barreau X, et al. Safety and efficacy of aneurysm treatment with WEB in the cumulative population of three prospective, multicenter series. J Neurointerv Surg. 2018;10(6):553-559. Arthur AS, Molyneux A, Coon AL, et al. The safety and effectiveness of the Woven EndoBridge (WEB) system for the treatment of wide-necked bifurcation aneurysms: final 12-month results of the pivotal WEB Intrasaccular Therapy (WEB-IT) Study. J Neurointerv Surg. 2019;11(9):924-930. Pierot L, Moret J, Turjman F, Herbreteau D, et al. WEB Treatment of Intracranial Aneurysms: Clinical and Anatomic Results in the French Observatory. AJNR. 2016. Spelle, L., et al. (2022) 'Clinical Assessment of WEB device in Ruptured Aneurysms (CLARYS): 12-month angiographic results of a multicenter study.' J NeuroIntervent Surg. Spelle, L., et al. (2024) 'Clinical Evaluation of WEB 17 device in intracranial aneurysms (CLEVER): 1-year effectiveness results for ruptured and unruptured aneurysms.' J NeuroIntervent Surg. Pierot L, Szikora I, Barreau X, et al. Aneurysm treatment with the Woven EndoBridge (WEB) device in the combined population of two prospective, multicenter series: 5-year follow-up. J Neurointerv Surg. 2023;15(6):552-557. Fiorella D, Molyneux A, Coon A, et al. Safety and effectiveness of the Woven EndoBridge (WEB) system for the treatment of wide necked bifurcation aneurysms: final 5 year results of the pivotal WEB Intra-saccular. Therapy study (WEB-IT). J Neurointerv Surg. 2023;15(12):1175-1180. Rai AT, Turner RC, Brotman RG, Boo S. Comparison of operating room variables, radiation exposure and implant costs for WEB versus stent assisted coiling for treatment of wide neck bifurcation aneurysms. Interv Neuroradiol. 2021;27(4):465-472. WEB™ is a trademark of MicroVention, Inc., registered in the United States and other jurisdictions. All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties. ©2024 MicroVention, Inc. MM2034(i) WW 03/25 Media Contact: + 1 714 206 9800
